Original Research ARTICLE
Identification of stage-specific gene expression signatures in response to retinoic acid during the neural differentiation of mouse embryonic stem cells
- 1 Health Risk Research Section, Center for Environmental Risk Research, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan
- 2 Department of Environmental Studies, Graduate School of Frontier Science, The University of Tokyo, Kashiwa, Chiba, Japan
- 3 Biological Impact Research Section, Center for Environmental Health Sciences, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan
- 4 Department of Animal Production Science, Graduate School of Agricultural Science, Tohoku University, Sendai, Miyagi, Japan
- 5 Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
We have previously established a protocol for the neural differentiation of mouse embryonic stem cells (mESCs) as an efficient tool to evaluate the neurodevelopmental toxicity of environmental chemicals. Here, we described a multivariate bioinformatic approach to identify the stage-specific gene sets associated with neural differentiation of mESCs. We exposed mESCs (B6G-2 cells) to 10−8 or 10−7 M of retinoic acid (RA) for 4 days during embryoid body formation and then performed morphological analysis on day of differentiation (DoD) 8 and 36, or genomic microarray analysis on DoD 0, 2, 8, and 36. Three gene sets, namely a literature-based gene set (set 1), an analysis-based gene set (set 2) using self-organizing map and principal component analysis, and an enrichment gene set (set 3), were selected by the combined use of knowledge from literatures and gene information selected from the microarray data. A gene network analysis for each gene set was then performed using Bayesian statistics to identify stage-specific gene expression signatures in response to RA during mESC neural differentiation. Our results showed that RA significantly increased the size of neurosphere, neuronal cells, and glial cells on DoD 36. In addition, the gene network analysis showed that glial fibrillary acidic protein, a neural marker, remarkably up-regulates the other genes in gene set 1 and 3, and Gbx2, a neural development marker, significantly up-regulates the other genes in gene set 2 on DoD 36 in the presence of RA. These findings suggest that our protocol for identification of developmental stage-specific gene expression and interaction is a useful method for the screening of environmental chemical toxicity during neurodevelopmental periods.
Humans are exposed to environmental chemicals on a daily basis; however, many effects of these chemicals on human health are unclear. Currently, assessment of developmental toxicity on children’s health is a large and rapidly growing research field. Children are not “little adults” and have special vulnerabilities to the toxic effects of environmental chemicals. For example, brain development during embryonic stages is an important period when microstructures are formed and axon guidance and synapse formation are induced by neuronal signaling (Lamoury et al., 2006; Ligon et al., 2006). These processes are regulated by stage-specific gene expression during embryonic development. Therefore, it is necessary to develop a more comprehensive and efficient system to identify the stage-specific gene expression signatures in embryonic development and to evaluate the toxicity of environmental chemicals on neural development.
Toxicity testing using embryonic stem cells (ESCs) has been developed as an efficient approach to assess the effect of environmental chemicals on neurodevelopment (Seiler et al., 2006). We have previously reported a mouse embryonic stem cell (mESC) neural differentiation protocol and showed that it could be used as an efficient tool to evaluate the toxic effects of environmental chemicals on neurodevelopment (Nagano et al., 2012). Furthermore, we have previously developed a method to quantitatively and statistically analyze microarray gene expression data using Bayesian networks with a log-linear functional relationship between genes (Toyoshiba et al., 2004, 2006). We proposed that advanced Bayesian network analysis is a necessary tool to understand the accurate linkage in the possible networks and the mechanism of the action of developmentally neurotoxic compounds.
During mammalian fetal development, the most active form of vitamin A, retinoic acid (RA) can pass through the umbilical cord to the fetus and induce axon formation and neural system development. ESCs express high levels of RA receptor (RAR)α in the undifferentiated stage, while RARβ begins to be expressed after embryoid body (EB) formation (Shiotsugu et al., 2004; Wilson and Maden, 2005; So et al., 2006). A series of RA concentrations were examined to detect neural cell identity during neuronal differentiation from mESC (Okada et al., 2004; Engberg et al., 2010). They reported that the 10−8 M of RA would be an optimum dose to induce cerebral and mesencephalic neurons and the 10−7 M of RA had capability to induce motor neurons (Kawasaki et al., 2000; Nishimura et al., 2003; Miyazaki et al., 2005).
Therefore, in the present study, we focused on identification of stage-specific gene expressions and analyzed their relationship network during mESC neurodevelopmental period after RA exposure at 10−8 and 10−7 M, using an advanced Bayesian network analysis.
Materials and Methods
Cell Culture and Differentiation
B6G-2 mESCs (RIKEN Cell Bank, Tsukuba, Ibaraki, Japan) were maintained in Dulbecco’s modified Eagle’s medium (Invitrogen, Carlsbad, CA, USA) supplemented with 15% knockout serum replacement (Invitrogen), 100 μM non-essential amino acids (Invitrogen), 100 μM 2-mercaptoethanol (Invitrogen), and 1000 U/ml leukemia inhibitory factor (LIF; Invitrogen) in gelatinized tissue culture dishes. On the first day of differentiation (DoD 0), cells were transferred in to 24 well plate in media without LIF and allowed to form EBs. The media was changed by every 2 days. RA was added during DoD 2–6 to induce neuronal differentiation. On DoD 8, EBs were transferred to L-ornithine/laminin-coated 24 well plates (BD Bio Coat, BD, Franklin Lakes, NJ, USA) and were cultured with neural medium from DoD 22 to DoD 36 to promote further neural differentiation (Figure 1A).
Figure 1. Experimental protocols and morphological analysis of the effect of RA on the neural differentiation of mESCs. (A) A Schematic diagram of cell cultures and chemical exposures. (B) Pictures of mESCs, EBs, and neurospheres (NS) with neurite growth derived from neurosphere in fluorescent fields. Green, blue, and red fluorescent images indicate GFP of cytoskeleton proteins, nuclei stained with Hoechst and neuronal cells and neurites stained with the anti Map2 antibody. Scale bar is 100 μm. (C) Morphological analysis of neuronal cell lineages exposed to RAs. Comparison of the EB areas on DoD 8 and DoD 36 showed that the EB area decreased with neuronal cell development. In RA-treated EBs, the numbers of Map2-positive axons and Gfap-positive cells were increased compared with the control. Symbols of C, R8, and R7 indicate vehicle control, RA 10−8 M, and RA 10−7 M.
Immunocytochemistry and Morphological Analysis
On DoD 8 and DoD 36, EBs, and their derivatives were fixed with 4% PFA in PBS for 15 min and then performed immunostaining with the conventional methods. Cells were incubated with primary antibodies overnight at 4°C at the following dilutions: anti-microtubule-associated protein 2 (Map2) antibody (Sigma-Aldrich, Poole, UK; 1:200) and mouse anti-glial fibrillary acidic protein (Gfap) monoclonal antibody (Chemicon International, Temecula, CA, USA; 1:200). Cells were rinsed with PBS and then incubated with Alexa-conjugated secondary antibodies (1:1000, Alexa Fluor 546, Invitrogen). Hoechst 33342 solution (Dojindo Laboratories, Kumamoto, Japan) was used for counter-staining. Immunofluorescence images were acquired with six biological replicates per condition using an IN Cell Analyzer 1000 (GE Healthcare, Buckinghamshire, UK) and analyzed using IN Cell Developer Tool Box 1.7 (GE Healthcare). All morphological analysis experiments were performed in triplicate to test the reproducibility of the results. Statistical analysis was performed using two-tailed Student’s t-test. Relationships were considered statistically significant with p < 0.05.
DNA Microarray Analysis
Total RNA was isolated on DoD 0, 2, 8, and 36 with six biological replicates. And then, single mixed RNA sample per condition was applied to Illumina MouseWG-6v1.0 expression BeadChips covering 46,643 transcripts including 26,766 annotated coding transcripts 2, according to the manufacturer’s instructions (Illumina, San Diego, CA, USA). The arrays were scanned in accordance with the manufacturer’s directions. Raw expression values of each gene were normalized with median centered by GeneSpring GX10.02 software (Agilent Technologies, Palo Alto, CA, USA). Normalized data were deposited in the National Center for Biotechnology Information Gene Expression Omnibus1 (accession no. GSE37602).
Selection of Gene Sets
To capture gene expression signatures of stage-specific changes during neural differentiation of mESCs, we performed three approaches to determine gene sets for Bayesian network analysis. Marker genes, which are commonly used to analyze pluripotency and development of neural cells, were selected as the literature-based gene set (set 1) by review of the published literature. The analysis-based gene set (set 2) was selected by the combined use of the knowledge-based database and the following classification methods. Candidate genes involved in axon guidance maps, the nerve growth factor (NGF) pathway, and RA signaling were preliminarily selected from the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database2 and then genes with specific expression patterns were identified using SOM and PCA. Finally, the enrichment gene set (set 3) was selected by clustering expression values of candidate genes contained in the Neurogenesis and Neural Stem Cell PCR Array (SABiosciences, Valencia, CA, USA) using SOM and PCA. SOM and PCA were performed using GeneSpring GX10.02 software (Agilent Technology). Briefly, SOM clustering was done by conditions in which similarity measure: euclidean, maximum number of iterations: 50, numbers of grid rows and columns were 2 × 4. Then each eight clusters of SOM were analyzed by PCA with four components of eigenvalues (component 1 was more than 40% and component 2 was 10%). To develop set 2 and 3, we collected genes with maximum and minimum values in the PCA component 1 from each SOM cluster.
Gene Interaction Network Analysis
We used a modified gene interaction network (GIN) based on our previous studies (Yamanaka et al., 2004; Toyoshiba et al., 2006; Nagano et al., 2012). The GIN was quantified to calculate the posterior probability distribution for the strength of the linkages based on gene expression and chemical exposure dose datasets. Briefly, a GIN consists of a collection of P nodes, denoted G1, G2, …, GP, with observed values n1, n2, … np. βij (i, j = 1, 2, …, P) are parameters in the log-linear function form describing the linkage from node i to node j. Mathematically, this is written as
where E[log(Gj)] represents the expectation for the natural logarithm of Gj, and Iij(i, j = 1, 2, …, P) is an indicator function that equals 1 if node Gi has a link to node Gj, otherwise it equals 0. If a node has a regulatory effect on node Gi, then that node is referred to as a “Parent of node Gi,” and we refer to it as belonging to the set Pa (Gi). The prior distribution for Iij was assumed to be a Bernoulli distribution with success probability pij when Iij = 1. In the uninformative case, pij could be set to 0.5 and if there is some expectation that Iij is not equal to zero, the prior probability could be set higher. The posterior distributions for the linkages were derived using Gibbs sampling. The network was used to evaluate the ability of the algorithm to have a higher posterior probability (p-value). Transition matrices were generated at p > 0.5.
Effects of RA on Neural Differentiation
Exposure to RA at different concentrations during EB formation induced neuronal and glial cell lineages from mESCs (Figure 1A). Morphological analysis with immunofluorescent staining showed that RA significantly increased the size of neurosphere, neuronal cells, and glial cells at DoD 36 (Figures 1B,C).
Gene Set Selection for Gene Network Analysis
To investigate transcriptomic changes as a result of neuronal differentiations and influences of RAs, a cDNA microarray was used to compare expression levels with and without the RA treatments in EB formations and neurosphere developments by hierarchical clustering methods (Figure 2A). From 22,188 transcripts presented from eight microarrays, 1,157 transcripts with expression differences greater than 2.0-fold in at least 1 microarray were selected for further analysis. From the microarray analysis, Nanog as a marker of undifferentiated ESCs and, Nestin, Map2, and Gfap as markers of neural cells were differentially expressed by RA treatments at differential doses during the neural differentiation of mESCs, suggesting that our protocol could detect the effects of RA on neuronal differentiation (Figure 2B). A high level of Nanog expression on DoD 8 was decreased in a dose-dependent fashion following RA treatments, but not on DoD 36. Nestin expression was increased by the 10−7 M RA treatment on DoD 8 and DoD 36. Map2 and Gfap expressions were also increased by RA treatments on DoD 8 and DoD 36 (Figure 2B).
Figure 2. Gene expression analysis by DNA microarray and gene selection strategies for the Bayesian network analysis of differentiation of neuronal cells derived from mESCs. (A) Heat map of hierarchical clustering generated from DNA microarray data. Color-coding in the heat map is that blue from red indicates – 4.0 from 4.0 log2 normalized intensity value by ES values, indicating that red is for up regulation and blue is for down regulation. (B) Gene expression of pluripotency and differentiation markers in mESCs, EB, and NS measured in DNA microarray. Symbols of C, R8, and R7 indicate vehicle control, RA 10−8 M, and RA 10−7 M. (C) Stage-specific gene expression signatures in response to RA during the neural differentiation of mESCs were identified as follows: set 1 was a set of genes selected from the literature; set 2 was selected by SOM and PCA after selecting 36 genes from pathway maps; set 3 was selected by SOM and PCA after selecting 159 genes from pathway maps. Expression values of microarray data corresponding to genes in these three sets were used for the Bayesian network analysis.
Three gene sets were selected for the Bayesian network analysis by our strategies as shown in Figure 2C. Selected gene sets are listed in Table 1. Concretely, set 1 was selected by the review of published articles and included Nanog (Mitsui et al., 2003; Loh et al., 2006), Pou5f1 (Okazawa et al., 1991; Catena et al., 2004; Akamatsu et al., 2009), Zfl42 (Shi et al., 2006; Scotland et al., 2009), Fgfr1 (Jukkola et al., 2006; Yang et al., 2008; Lee et al., 2009), Sox2 (Tomioka et al., 2002; Graham et al., 2003; Tanaka et al., 2004; Jin et al., 2009), and Oligo2 (Ahn et al., 2008). RARs were also added to set 1 to assess the effects of RA. Set 2 was selected by the combined use of the KEGG database and SOM and PCA classification methods. Firstly, a list of 36 candidate genes was compiled according to axon guidance, NGF pathway, and RA signaling of KEGG database. It is known that NGF can induce neuronal differentiation of mESCs (Schuldiner et al., 2001) while RA can induce the expression of the NGF receptor (p75) during the neuronal differentiation of PC12 cells (Cosgaya et al., 1996). Therefore, genes in the NGF pathway were selected as indicators to assess the effects of RA on the neural differentiation of mESCs. The 36 candidate genes were then classified in to 17 classes by SOM, and representative genes were selected from each class by PCA. Finally, 16 genes were selected for set 3 by SOM and PCA clustering from 159 candidate genes contained in the Neurogenesis and Neural Stem Cell PCR Array (SABiosciences). Furthermore, specific markers for astrocytes (Gfap), mature neurons (Map2), neuronal stem cells (Nestin), and young neurons (Tuj1) were added to sets 2 and 3 to assess the stage of neuronal differentiation.
Gene Interaction Analysis
Matrices transferred from gene interaction analysis for set 1, set 2, and set 3 are shown in Figures 3–5, respectively (see Figures A1–A3 in Appendix as references and Tables S1–S6 in Supplementary Material for input data and output raw-results). In the control group of set 1, Nanog, and Sox2 (Figure 3) which control ESC pluripotency, regulate many other genes on DoD 0, 2, and 8. On DoD 36, Sox2 does not regulate any gene. In RA-treated groups of set 1, linkages of RARs in the matrix indicated that these genes might play principal roles in the regulation of expression of other genes. Briefly, the effect of RA was observed on DoD 8, in which RA 10−8 or 10−7 M aggravated Nanog and Pou5f1. On DoD 36, the matrix was more strongly influenced by RA, in which the neural marker genes such as Gfap and Map2 up-regulated the other genes, indicating that RA enhances neural differentiation (Figure 3).
Figure 3. Matrices in gene interaction networks of the literature-based gene set (set 1) in mESCs, EB, and NP of neuronal differentiation. Gene Symbols, RARa, RARb, RARg, Nanog, Pou5f1, Zfp42, Fgfr1, Olig2, Sox2, Gfap, Map2, Nestin, Tuj1, line up in order of up to down in the y axis and left to right in the x axis. Red indicates upregulated genes and blue indicates downregulated genes. Red indicates that genes from the y axis upregulated genes from the x axis. Blue indicates that genes from the y axis downregulated genes from the x axis. Symbols of C, R8, and R7 indicate vehicle control, RA 10−8 M, and RA 10−7 M.
Figure 4. Matrices in gene interaction networks of the analysis-based gene set (set 2) in mESCs, EB, and NP of neuronal differentiation. Gene Symbols, Map2k1, Mapk1, Mapk3, Pla2g6, Rps6ka1, Shc1, Atbf1, Cdv1, Rhog, Rif1, Sall1, Smarcad1, Fos, Gbx2, Hras1, Raf1, Sox2, Gfap, Map2, Nestin, Tuji1 line up in order of up to down in the y axis and left to right in the x axis. Red indicates upregulated genes and blue indicates down regulated genes. Red indicates that genes from the y axis up regulated genes from the x axis. Blue indicates that genes from the y axis downregulated genes from the x axis. Symbols of C, R8, and R7 indicate vehicle control, RA 10−8 M, and RA 10−7 M.
Figure 5. Matrices in gene interaction networks of the enrichment gene set (set 3) in mESCs, EB, and NP of neuronal differentiation. Gene Symbols, Adora2a, Drd5, Fgf13, Gnao1, Notch2, Tnr, Ascl1, Gusb, Mef2c, Pax5, Pou3f3, Bdnf, Gdnf, Nrp2, Slit2, Ywhah, Gfap, Map2, Nestin, Tuji1 line up in order of up to down in the y axis and left to right in the x axis. Red indicates up regulated genes and blue indicates down regulated genes. Red indicates that genes from the y axis up regulated genes from the x axis. Blue indicates that genes from the y axis down regulated genes from the x axis. Symbols of C, R8, and R7 indicate vehicle control, RA 10−8 M, and RA 10−7 M.
Gene interaction matrix analysis for set 2 is shown in Figure 4. In the mESC matrix, linkages between genes were concentrated to categories of pathway signaling and neural development, which is similar with those in set 1 on DoD 8 and DoD 36. It is noteworthy that Gbx2 as a neuronal development marker strongly up-regulated Mapk3, Atbf1, Rhog, Sall1, Smarcad, Sox2, and Map2 on DoD 8 as well as DoD 36 in RA 10−8 M matrices. RA-treated matrices showed that linkages shifted to the right side of the matrix with increasing RA concentrations. Finally, linkages on DoD 36 were concentrated to categories of neural development and neural markers.
Gene interaction network analysis for set 3 is shown in Figure 5. In the mESC matrix, linkages between genes were concentrated to transcription/chromatin regulation and pathway signaling categories. Linkages between genes in the control matrix on DoD 8 were concentrated to pathway signaling and neural development categories. In the RA-treated matrices, linkages between genes moved to the neural marker category from the neural development category in a dose-dependent manner. Most of the linkages between genes in the RA-treated matrices on DoD 36 were concentrated to pathway signaling and neural marker categories, suggesting that Gfap mainly regulates neuronal differentiation.
In the present study, a prediction model for the neural differentiation of mESCs was established and stage-specific gene expression signatures in response to RA were identified using Bayesian network analysis. Our present findings showed that RA significantly increased the size of neurosphere, neuronal cells, and glial cells on DoD 36. In addition, neural marker Gfap remarkably up-regulated the other genes in gene set 1 and 3, and neural development marker Gbx2 significantly up-regulated the other genes in gene set 2 on DoD 36 in the presence of RA. These findings suggest that our protocol for identification of developmental stage-specific gene expression and interaction is a useful method for the screening of environmental chemical toxicity during neurodevelopmental periods.
RA is known as a severe teratogen and causes central nervous system malformations. However, in vivo study indicated that high dose (70 mg/kg body weight; b.w.) of RA could induce teratogenic effects during gestational day 7–9 in Swiss mice (Veiga Quemelo et al., 2007). In addition, it was reported that the physiological dose that cannot affect RAR level was 1 mg/kg b.w. and minimally teratogenic dose was 10 mg/kg b.w. and completely teratogenic dose was 100 mg/kg b.w. in gestational day 9 of mouse (Harnisha et al., 1990). In the present study, we selected the dose of RA as 10−8 and 10−7 M because endogenous levels of RA-induced neural differentiation in the early embryo are approximately 1–10 nM (Maden et al., 1998; Mic et al., 2003). Therefore, we considered to use 10−8 M as a low dose and 10−7 M as a high dose to examine the effect of RA on stage-specific gene expression signature in mESCs.
We have also successfully designed a mESC neural differentiation protocol to evaluate the effect of RA on the neural differentiation of mESCs. Morphological analysis using a high-content image analyzer was able to acquire varying differences of differentiation from mESCs to neural cells by the RA treatment. For instance, neuronal or glial differentiation from neuronal ESCs was delayed in control cells without induction by RA, which was further confirmed by the lower expression levels of Map2 and Gfap detected on DoD 36. RA treatments promoted the loss of pluripotency and differentiation into neural ESCs up to DoD 36 in the present study (Figures 1B,C), suggesting that the maturation of Map2-positive neurons and Gfap-positive astrocytes were accelerated by RA treatment. Our results are consistent with a study showing that RA and LIF enhance the induction of Gfap-positive astrocytes from mice neural progenitor cells via epigenetic modifications (Asano et al., 2009).
In restricted sample size analysis like the present study, simulations using Bayesian network analysis have been suggested to be a very effective method (Toyoshiba et al., 2006). Our present study provided a new experimental evidence that Bayesian network analysis was effective to identify the functions of the well-known neural development regulators, such as Gfap and SOX2 (Figures 3–5), in response to RA during the neural differentiation of mESCs and suggested its further application to predict developmental neurotoxicity of environmental chemicals. However, in the simulation analysis, one major problem is to select genetic markers related with a trait of interest. To perform accurate simulation, it is undesirable to select genes with similar expression patterns. Similar variables could significantly affect the analysis results and potentially lead to biased results. Hence, the selection of genes with distinct expression patterns, which can represent each stage of mESC neural differentiation, seems to be important in the outcome of the GIN analysis. In this study, we selected gene sets for GIN analysis by the combined use of two classification methods, SOM and PCA. SOM is a powerful data mining method, whose algorithm is an unsupervised competitive learning neural network and it maps high-dimensional data into a simple low-dimensional display (Kohonen, 1990; Zhang et al., 2008). Therefore, SOM is able to classify the temporal expression data for each gene. After classification by SOM based on gene expression patterns, the representative genes were further selected from each class by PCA. PCA is a standard technique of pattern recognition and has been widely used as a tool in exploratory data analysis and for making predictive models in many biological systems (Aiba et al., 2006; van Dartel et al., 2010; Qin et al., 2011). In this study, the genes selected by SOM and PCA were shown to have adequate simulation parameters to evaluate the effects of RA on the neural differentiation of mESCs.
Finally, our prediction model, employing Bayesian network analysis, showed that it is possible to capture genetic correlations between genes and to identify slight variations for different conditions. We performed the same prediction model for three gene sets of different genetic constitution. Our study indicated that the GIN was able to capture features of each developmental stage during the neural differentiation of mESCs. RA treatment could change the network structure in a dose-dependent manner. In addition, among the three gene sets, set 3 was the best according to the morphological results. We found that the Gfap gene was linked with other genes in the RA 10−7 M matrix in the GIN analysis, while the number of Gfap-positive cells was markedly increased by RA 10−7 M treatment on DoD 36 in the morphological analysis. This suggested that the approach used in this study, of the independent selection of gene sets using SOM or PCA, was efficient. This Bayesian model might also be useful to investigate the developmental toxicity of environmental chemicals other than RA.
In summary, to find the optimized GIN that integrated chemical effects, we created three different gene sets and then performed GIN analysis using Bayesian network algorithms to capture the stage-specific gene expression signatures in response to RA treatment during the neural differentiation of mESCs. “Toxicity Testing in the Twenty First Century – A vision and a strategy” issued by the US Nuclear Regulatory Commission indicated that the most important issue for toxicity testing is how to connect the extensive body of toxicity information to high-throughput screening to perform chemical risk assessment (Thomas et al., 2007; Davis et al., 2008; Ellinger-Ziegelbauer et al., 2009; Hubal, 2009). Here, we described a novel approach to identify stage-specific gene expression in embryonic development and suggested its application to evaluate the neural developmental toxicity of environmental chemicals in future studies.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
This study was supported, in part, by the Environmental Technology Development Fund (to Hideko Sone) from the Ministry of the Environment and by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare, Japan (to Seiichiroh Ohsako). The authors gratefully acknowledge the technical support of Ms Noriko Oshima (GE Healthcare Corporation, Japan) for analysis using the IN Cell Analyzer 1000.
The Supplementary Material for this article can be found online at: http://www.frontiersin.org/Toxicogenomics_/10.3389/fgene.2012.00141/abstract
Table S1. Input data of gene expression values for set 1. Values are normalized expression values in beads of each gene with approximate 30 replicates.
Table S2. Input data of gene expression values for set 2. Values are normalized expression values in beads of each gene with approximate 30 replicates.
Table S3. Input data of gene expression values for set 3. Values are normalized expression values in beads of each gene with approximate 30 replicates.
Table S4. Output results of the Bayesian network analysis with gene expression values for set 1. Values are posterior probabilities.
Table S5. Output results of the Bayesian network analysis with gene expression values for set 2. Values are posterior probabilities.
Table S6. Output results of the Bayesian network analysis with gene expression values for set 3. Values are posterior probabilities.
Ahn, S. M., Byun, K., Kim, D., Lee, K., Yoo, J. S., Kim, S. U., Jho, E. H., Simpson, R. J., and Lee, B. (2008). Olig2-induced neural stem cell differentiation involves downregulation of Wnt signaling and induction of Dickkopf-1 expression. PLoS ONE 3, e3917. doi:10.1371/journal.pone.0003917
Aiba, K., Sharov, A. A., Carter, M. G., Foroni, C., Vescovi, A. L., and Ko, M. S. (2006). Defining a developmental path to neural fate by global expression profiling of mouse embryonic stem cells and adult neural stem/progenitor cells. Stem Cells 24, 889–895.
Akamatsu, W., Deveale, B., Okano, H., Cooney, A. J., and van der Kooy, D. (2009). Suppression of Oct-4 by germ cell nuclear factor restricts pluripotency and promotes neural stem cell development in the early neural lineage. J. Neurosci. 29, 2113–2124.
Asano, H., Aonuma, M., Sanosaka, T., Kohyama, J., Namihira, M., and Nakashima, K. (2009). Astrocyte differentiation of neural precursor cells is enhanced by retinoic acid through a change in epigenetic modification. Stem Cells 27, 2744–2752.
Catena, R., Tiveron, C., Ronchi, A., Porta, S., Ferri, A., Tatangelo, L., Cavallaro, M., Favaro, R., Ottolenghi, S., Reinbold, R., Schöler, H., and Nicolis, S. K. (2004). Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. J. Biol. Chem. 279, 41846–41857.
Cosgaya, J. M., Garcia-Villalba, P., Perona, R., and Aranda, A. (1996). Comparison of the effects of retinoic acid and nerve growth factor on PC12 cell proliferation, differentiation, and gene expression. J. Neurochem. 66, 89–98.
Davis, A. P., Murphy, C. G., Rosenstein, M. C., Wiegers, T. C., and Mattingly, C. J. (2008). The Comparative Toxicogenomics Database facilitates identification and understanding of chemical-gene-disease associations: arsenic as a case study. BMC Med. Genomics 1, 48. doi:10.1186/1755-8794-1-48
Ellinger-Ziegelbauer, H., Fostel, J. M., Aruga, C., Bauer, D., Boitier, E., Deng, S. B., Dickinson, D., Le Fevre, A. C., Fornace, A. J., Grenet, O., Gu, Y. Z., Hoflack, J. C., Shiiyama, M., Smith, R., Snyder, R. D., Spire, C., Tanaka, G., and Aubrechtk, J. (2009). Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms. Toxicol. Sci. 110, 341–352.
Engberg, N., Kahn, M., Petersen, D. R., Hansson, M., and Serup, P. (2010). Retinoic acid synthesis promotes development of neural progenitors from mouse embryonic stem cells by suppressing endogenous, Wnt-dependent nodal signaling. Stem Cells 28, 1498–1509.
Harnisha, D. C., Baruad, A. B., Sopranob, K. J., and Soprano, D. R. (1990). Induction of β-retinoic acid receptor mRNA by teratogenic doses of retinoids in murine fetuses. Differentiation 45, 103–108.
Jin, Z., Liu, L., Bian, W., Chen, Y., Xu, G., Cheng, L., and Jing, N. (2009). Different transcription factors regulate nestin gene expression during P19 cell neural differentiation and central nervous system development. J. Biol. Chem. 284, 8160–8173.
Jukkola, T., Lahti, L., Naserke, T., Wurst, W., and Partanen, J. (2006). FGF regulated gene-expression and neuronal differentiation in the developing midbrain-hindbrain region. Dev. Biol. 297, 141–157.
Kawasaki, H., Mizuseki, K., Nishikawa, S., Kaneko, S., Kuwana, Y., Nakanishi, S., Nishikawa, S. I., and Sasai, Y. (2000). Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28, 31–40.
Lamoury, F. M. J., Croitoru-Lamoury, J., and Brew, B. J. (2006). Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1. Cytotherapy 8, 228–242.
Lee, D. C., Hsu, Y. C., Chung, Y.-F., Hsiao, C. Y., Chen, S. L., Chen, M.-S., Lin, H. K., and Chiu, I.-M. (2009). Isolation of neural stem/progenitor cells by using EGF/FGF1 and FGF1B promoter-driven green fluorescence from embryonic and adult mouse brains. Mol. Cell. Neurosci. 41, 348–363.
Ligon, K. L., Kesari, S., Kitada, M., Sun, T., Arnett, H. A., Alberta, J. A., Anderson, D. J., Stiles, C. D., and Rowitch, D. H. (2006). Development of NG2 neural progenitor cells requires Olig gene function. Proc. Natl. Acad. Sci. U.S.A. 103, 7853–7858.
Loh, Y. H., Wu, Q., Chew, J. L., Vega, V. B., Zhang, W., Chen, X., Bourque, G., George, J., Leong, B., Liu, J., Wong, K. Y., Sung, K. W., Lee, C. W., Zhao, X. D., Chiu, K. P., Lipovich, L., Kuznetsov, V. A., Robson, P., Stanton, L. W., Wei, C. L., Ruan, Y., Lim, B., and Ng, H. H. (2006). The Oct-4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38, 431–440.
Maden, M., Sonneveld, E., van der Saag, P. T., and Gale, E. (1998). The distribution of endogenous retinoic acid in the chick embryo: implications for developmental mechanisms. Development 125, 4133–4144.
Mic, F. A., Molotkov, A., Benbrook, D. M., and Duester, G. (2003). Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proc. Natl. Acad. Sci. U.S.A. 100, 7135–7140.
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M., and Yamanaka, S. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES Cells. Cell 113, 631–642.
Miyazaki, K., Narita, N., and Narita, M. (2005). Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int. J. Dev. Neurosci. 23, 287–297.
Nagano, R., Akanuma, H., Qin, X. Y., Imanishi, S., Toyoshiba, H., Yoshinaga, J., Ohsako, S., and Sone, H. (2012). Multi-parametric profiling network based on gene expression and phenotype data: a novel approach to developmental neurotoxicity testing. Int. J. Mol. Sci. 13, 187–207.
Nishimura, F., Yoshikawa, M., Kanda, S., Nonaka, M., Yokota, H., Shiroi, A., Nakase, H., Hirabayashi, H., Ouji, Y., Birumachi, J., Ishizaka, S., and Sakaki, T. (2003). Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells 21, 171–180.
Okada, Y., Shimazaki, T., Sobue, G., and Okano, H. (2004). Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells. Dev. Biol. 275, 124–142.
Okazawa, H., Okamoto, K., Ishino, F., Ishinokaneko, T., Takeda, S., Toyoda, Y., Muramatsu, M., and Hamada, H. (1991). The Oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. EMBO J. 10, 2997–3005.
Qin, X. Y., Wei, F., Yoshinaga, J., Yonemoto, J., Tanokura, M., and Sone, H. (2011). siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells. FEBS Lett. 585, 3310–3315.
Schuldiner, M., Eiges, R., Eden, A., Yanuka, O., Itskovitz-Eldor, J., Goldstein, R. S., and Benvenisty, N. (2001). Induced neuronal differentiation of human embryonic stem cells. Brain Res. 913, 201–205.
Shiotsugu, J., Katsuyama, Y., Arima, K., Baxter, A., Koide, T., Song, J., Chandraratna, R. A., and Blumberg, B. (2004). Multiple points of interaction between retinoic acid and FGF signaling during embryonic axis formation. Development 131, 2653–2667.
So, P. L., Yip, P. K., Bunting, S., Wong, L. F., Mazarakis, N. D., Hall, S., Mcmahon, S., Maden, M., and Corcoran, J. P. (2006). Interactions between retinoic acid, nerve growth factor and sonic hedgehog signalling pathways in neurite outgrowth. Dev. Biol. 298, 167–175.
Tanaka, S., Kamachi, Y., Tanouchi, A., Hamada, H., Jing, N., and Kondoh, H. (2004). Interplay of SOX and POU factors in regulation of the Nestin gene in neural primordial cells. Mol. Cell. Biol. 24, 8834–8846.
Thomas, R. S., Allen, B. C., Nong, A., Yang, L., Bermudez, E., Clewell, H. J., and Andersen, M. E. (2007). A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol. Sci. 98, 240–248.
Tomioka, M., Nishimoto, M., Miyagi, S., Katayanagi, T., Fukui, N., Niwa, H., Muramatsu, M., and Okuda, A. (2002). Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res. 30, 3202–3213.
Toyoshiba, H., Sone, H., Yamanaka, T., Parham, F. M., Irwin, R. D., Boorman, G. A., and Portier, C. J. (2006). Gene interaction network analysis suggests differences between high and low doses of acetaminophen. Toxicol. Appl. Pharmacol. 215, 306–316.
Toyoshiba, H., Yamanaka, T., Sone, H., Parham, F. M., Walker, N. J., Martinez, J., and Portier, C. J. (2004). Gene interaction network suggests dioxin induces a significant linkage between aryl hydrocarbon receptor and retinoic acid receptor beta. Environ. Health Perspect. 112, 1217–1224.
van Dartel, D. A. M., Pennings, J. L. A., Van Schooten, F. J., and Piersma, A. H. (2010). Transcriptomics-based identification of developmental toxicants through their interference with cardiomyocyte differentiation of embryonic stem cells. Toxicol. Appl. Pharmacol. 243, 420–428.
Yamanaka, T., Toyoshiba, H., Sone, H., Parham, F. M., and Portier, C. J. (2004). The TAO-Gen algorithm for identifying gene interaction networks with application to SOS repair in E. coli. Environ. Health Perspect. 112, 1614–1621.
Yang, H., Xia, Y., Lu, S. Q., Soong, T. W., and Feng, Z. W. (2008). Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1. J. Biol. Chem. 283, 5287–5295.
Zhang, Y. J., Xuan, J. H., de los Reyes, B. G., Clarke, R., and Ressom, H. W. (2008). Network motif-based identification of transcription factor-target gene relationships by integrating multi-source biological data. BMC Bioinformatics 9, 203. doi:10.1186/1471-2105-9-203
Figure A1. Gene interaction networks of the literature-based gene set (set 1) in mESCs, EB, and NP of neuronal differentiation. The optimized network was generated at p > 0.300. Red indicates that parent genes up-regulate children genes. Blue indicates that parent genes down-regulate children genes.
Figure A2. Gene interaction networks of the analysis-based gene set (set 2) in mESCs, EB, and NP of neuronal differentiation. The optimized network was generated at p > 0.300. Red indicates that parent genes up-regulate children genes. Blue indicates that parent genes down-regulate children genes.
Keywords: mouse embryonic stem cells, neural differentiation, Bayesian network, retinoic acid, toxicity screening
Citation: Akanuma H, Qin X-Y, Nagano R, Win-Shwe T-T, Imanishi S, Zaha H, Yoshinaga J, Fukuda T, Ohsako S and Sone H (2012) Identification of stage-specific gene expression signatures in response to retinoic acid during the neural differentiation of mouse embryonic stem cells. Front. Gene. 3:141. doi: 10.3389/fgene.2012.00141
Received: 27 March 2012; Accepted: 12 July 2012;
Published online: 07 August 2012.
Edited by:Pierre R. Bushel, National Institute of Environmental Health Sciences, USA
Reviewed by:Ryou Fukushima, Shionogi & Co., Ltd., Japan
Manikandan Jayapal, King Abdulaziz University, Saudi Arabia
Copyright: © 2012 Akanuma, Qin, Nagano, Win-Shwe, Imanishi, Zaha, Yoshinaga, Fukuda, Ohsako and Sone. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
*Correspondence: Hideko Sone, Health Risk Research Section, Center for Environmental Risk Research, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba 305-8506, Japan. e-mail: firstname.lastname@example.org